𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Growth factors and cytokines in the prevention and treatment of oral and gastrointestinal mucositis

✍ Scribed by Inger von Bültzingslöwen; Michael T. Brennan; Fred K. L. Spijkervet; Richard Logan; Andrea Stringer; Judith E. Raber-Durlacher; Dorothy Keefe

Publisher
Springer-Verlag
Year
2006
Tongue
English
Weight
140 KB
Volume
14
Category
Article
ISSN
0941-4355

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical practice guidelines for the pre
Clinical practice guidelines for the prevention and treatment of cancer therapy–induced oral and gastrointestinal mucositis
✍ Edward B. Rubenstein; Douglas E. Peterson; Mark Schubert; Dorothy Keefe; Deborah 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB 👁 2 views

## BACKGROUND. Oral and gastrointestinal (GI) mucositis can affect up to 100% of patients undergoing high-dose chemotherapy and hematopoietic stem cell transplantation, 80% of patients with malignancies of the head and neck receiving radiotherapy, and a wide range of patients receiving chemotherap

Updated clinical practice guidelines for
Updated clinical practice guidelines for the prevention and treatment of mucositis
✍ Dorothy M. Keefe; Mark M. Schubert; Linda S. Elting; Stephen T. Sonis; Joel B. E 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 2 views

## Abstract Considerable progress in research and clinical application has been made since the original guidelines for managing mucositis in cancer patients were published in 2004, and the first active drug for the prevention and treatment of this condition has been approved by the United States Fo